Marion Dorsch - Net Worth and Insider Trading
Marion Dorsch Net Worth
The estimated net worth of Marion Dorsch is at least $2 Million dollars as of 2024-11-10. Marion Dorsch is the Chief Scientific Officer of Blueprint Medicines Corp and owns about 15,250 shares of Blueprint Medicines Corp (BPMC) stock worth over $2 Million. Details can be seen in Marion Dorsch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marion Dorsch has not made any transactions after 2021-02-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Marion Dorsch
Marion Dorsch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marion Dorsch owns 1 companies in total, including Blueprint Medicines Corp (BPMC) .
Click here to see the complete history of Marion Dorsch’s form 4 insider trades.
Insider Ownership Summary of Marion Dorsch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2021-02-22 | Chief Scientific Officer |
Marion Dorsch Latest Holdings Summary
Marion Dorsch currently owns a total of 1 stock. Marion Dorsch owns 15,250 shares of Blueprint Medicines Corp (BPMC) as of February 22, 2021, with a value of $2 Million.
Latest Holdings of Marion Dorsch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2021-02-22 | 15,250 | 100.83 | 1,537,658 |
Holding Weightings of Marion Dorsch
Marion Dorsch Form 4 Trading Tracker
According to the SEC Form 4 filings, Marion Dorsch has made a total of 8 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 7,578 shares on February 22, 2021, which brought Marion Dorsch around $757,800.
Insider Trading History of Marion Dorsch
- 1
Marion Dorsch Trading Performance
Marion Dorsch Ownership Network
Ownership Network List of Marion Dorsch
Ownership Network Relation of Marion Dorsch
Marion Dorsch Owned Company Details
What does Blueprint Medicines Corp do?
Who are the key executives at Blueprint Medicines Corp?
Marion Dorsch is the Chief Scientific Officer of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include President & R and D Fouad Namouni , director & CEO & President Jeffrey W. Albers , and Principal FAO Michael Landsittel .
Blueprint Medicines Corp (BPMC) Insider Trades Summary
Over the past 18 months, Marion Dorsch made no insider transaction in Blueprint Medicines Corp (BPMC). Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 165,808 shares made by Jeffrey W. Albers , a net sale of 38,146 shares made by Michael Landsittel , and a net sale of 14,415 shares made by Ariel Hurley .
In summary, during the past 3 months, insiders sold 27,744 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 27,744 shares. During the past 18 months, 464,866 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 464,866 shares.
Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Blueprint Medicines Corp Insider Transactions
Marion Dorsch Mailing Address
Above is the net worth, insider trading, and ownership report for Marion Dorsch. You might contact Marion Dorsch via mailing address: Blueprint Medicines Corporation, 38 Sidney Street, Suite 200, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
